Rosenson RS - Search Results

1

Fenofibrate: treatment of hyperlipidemia and beyond.

Rosenson RS. Rosenson RS. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1319-30. doi: 10.1586/14779072.6.10.1319. Expert Rev Cardiovasc Ther. 2008. PMID: 19018684 Review.

2

Biomarkers, atherosclerosis and cardiovascular events.

Rosenson RS. Rosenson RS. Expert Rev Cardiovasc Ther. 2008 Jun;6(5):619-22. doi: 10.1586/14779072.6.5.619. Expert Rev Cardiovasc Ther. 2008. PMID: 18510479 Review.

3

Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.

Rosenson RS, Wolff DA, Huskin AL, Helenowski IB, Rademaker AW. Rosenson RS, et al. Diabetes Care. 2007 Aug;30(8):1945-51. doi: 10.2337/dc07-0015. Epub 2007 May 4. Diabetes Care. 2007. PMID: 17483155 Clinical Trial.

4

Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.

Rosenson RS, Huskin AL, Wolff DA, Helenowski IB, Rademaker AW. Rosenson RS, et al. Atherosclerosis. 2008 Jun;198(2):381-8. doi: 10.1016/j.atherosclerosis.2007.12.007. Epub 2008 Feb 1. Atherosclerosis. 2008. PMID: 18242616 Clinical Trial.

5

Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.

Rosenson RS. Rosenson RS. Obesity (Silver Spring). 2009 Mar;17(3):504-9. doi: 10.1038/oby.2008.530. Epub 2008 Nov 20. Obesity (Silver Spring). 2009. PMID: 19023279 Free article. Clinical Trial.

6

Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.

Rosenson RS. Rosenson RS. Am Heart J. 2008 Mar;155(3):499.e9-16. doi: 10.1016/j.ahj.2007.12.012. Epub 2008 Jan 31. Am Heart J. 2008. PMID: 18294485 Clinical Trial.

7

Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events.

Rubenfire M, Brook RD, Rosenson RS. Rubenfire M, et al. Among authors: rosenson rs. Am J Med. 2010 Oct;123(10):892-8. doi: 10.1016/j.amjmed.2010.03.024. Am J Med. 2010. PMID: 20920687 Review.

8

Critical appraisal of revised cholesterol guidelines for the very high-risk patient.

Rosenson R, Lloyd-Jones D; Working group from the Adult Treatment Panel III of the National Cholesterol Educational Program. Rosenson R, et al. Expert Rev Cardiovasc Ther. 2005 Jan;3(1):173-8. doi: 10.1586/14779072.1.3.173. Expert Rev Cardiovasc Ther. 2005. PMID: 15739256 Review.

9

Heterogeneous postprandial lipoprotein responses in the metabolic syndrome, and response to fenofibrate therapy.

Rosenson RS, Helenowski IB, Tangney CC. Rosenson RS, et al. Cardiovasc Drugs Ther. 2010 Dec;24(5-6):439-47. doi: 10.1007/s10557-010-6264-6. Cardiovasc Drugs Ther. 2010. PMID: 20922563 Clinical Trial.

10

Management of hyperlipidemia in older adults.

Alexander KP, Blazing MA, Rosenson RS, Hazard E, Aronow WS, Smith SC Jr, Ohman EM. Alexander KP, et al. Among authors: rosenson rs. J Cardiovasc Pharmacol Ther. 2009 Mar;14(1):49-58. doi: 10.1177/1074248408328927. Epub 2009 Jan 5. J Cardiovasc Pharmacol Ther. 2009. PMID: 19124599 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page